DEF 14A 03162016

Company

CUMBERLAND PHARMACEUTICALS INC

Filed

March 16, 2016

Period of Report

April 26, 2016

Accession Number

0001628280-16-012728

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →